3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
12
Osteosarcoma
9
Rhabdomyosarcoma
7
Neuroblastoma
7
Wilms Tumor
6
Rhabdoid Tumor
6
Lymphoma, Non-Hodgkin
6
Hepatoblastoma
6
Sarcoma, Ewing
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Glioma
5
Ependymoma
5
Central Nervous System Neoplasms
4
Liposarcoma
3
Carcinosarcoma
3
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Melanoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Cervical Neoplasms
1
Interventions
Cyclophosphamide
9
Doxorubicin
8
Vincristine
6
Etoposide
6
Ifosfamide
5
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Cisplatin
3
Carboplatin
3
seclidemstat
2
Temozolomide
2
Tacrolimus
2
Neoadjuvant Therapy
2
Irinotecan
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
Brachytherapy
2
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
X-Rays
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled